Related Experiment Video
Updated: Feb 18, 2026
07:59
Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
1.8K
[Nasopharyngeal carcinoma: present and future]
1Laboratorie de Virologie MolécuPaire, I.V.M.C. UMR5537, Faculté de Médecine R.T.H. Laënnec, Université Claude Bernard-Lyon I.
Nihon Rinsho. Japanese Journal of Clinical Medicine
|February 1, 1997
Summary
Nasopharyngeal carcinoma (NPC), a significant health issue in Asia and North Africa, is strongly linked to the Epstein-Barr virus (EBV). Research explores if EBV is the sole cause of NPC, investigating viral proteins and genetic factors.
Area of Science:
- Oncology
- Virology
- Genetics
Context:
- Nasopharyngeal carcinoma (NPC) is a major public health concern in Southeast Asia and North Africa.
- The Epstein-Barr virus (EBV) is consistently found in NPC malignant cells, suggesting a key role.
Purpose:
- To investigate the role of Epstein-Barr virus (EBV) in the development of nasopharyngeal carcinoma (NPC).
- To determine if EBV is the sole causative agent in NPC pathogenesis.
Summary:
- The presence of the EBV genome and expression of oncogenic viral proteins in all NPC malignant cells indicate a strong association.
- Activation of proto-oncogenes and potential deletions of anti-oncogenes in affected chromosomes are observed.
- Further research aims to elucidate the definitive role of EBV in NPC development.
Impact:
- Understanding the EBV-NPC link can lead to targeted prevention and treatment strategies.
- This research may clarify the etiological factors of NPC, improving public health outcomes in endemic regions.
Related Concept Videos
02:57Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
01:30Cancer Vaccines
1.1K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.1K
01:21Barrett Esophagus-II: Clinical Manifestations and Management
1.2K
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
1.2K
01:21Cancer Survival Analysis
787
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
787
02:07Tumor Progression
7.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.5K
02:56Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K